# Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus

> **NCT05898308** · PHASE4 · RECRUITING · sponsor: **University Hospital, Rouen** · enrollment: 133 (estimated)

## Conditions studied

- Pemphigus
- Dermatologic Disease

## Interventions

- **DRUG:** RiTUXimab Injection

## Key facts

- **NCT ID:** NCT05898308
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-04
- **Primary completion:** 2032-05-01
- **Final completion:** 2032-05-01
- **Target enrollment:** 133 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05898308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05898308, "Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05898308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*